Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: MGV who wrote (1179)	6/12/1999 1:40:00 PM
From: Feathered Propeller	Read Replies (2) \| Respond to of 1754

VISX shines Laser vision correction company VISX (VISX) soared 18-7/16 to 78-15/16, flying on the magic carpet of positive remarks from two investment firms and its own first-quarter profit prospects. In an overnight statement, the company said earnings will beat Wall Street estimates by as much as 50 percent, spurring Bank Boston Robertson Stephens to rate the stock a "buy," while Warburg upped its 1999 price target to $110 from $76. cnnfn.com